Mylan Labs announces final FDA approval for Azithromycin tablets

Co announces it has received final approval from the FDA for its Abbreviated New Drug Applications for Azithromycin Tablets, 250 mg and 500 mg. Azithromycin Tablets are the generic version of Pfizer's (PFE) Zithromax Tablets. Azithromycin Tablets had U.S. sales of approx $886 mln for the 12 months ending March 31, 2007, for the same strengths. This product will be shipped immediately.